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During blood-stage development, malaria parasites are challenged
with the detoxification of enormous amounts of heme released
during the proteolytic catabolism of erythrocytic hemoglobin.
They tackle this problem by sequestering heme into bioinert crys-
tals known as hemozoin. The mechanisms underlying this biomi-
neralization process remain enigmatic. Here, we demonstrate that
both rodent and human malaria parasite species secrete and in-
ternalize a lipocalin-like protein, PV5, to control heme crystalliza-
tion. Transcriptional deregulation of PV5 in the rodent parasite
Plasmodium berghei results in inordinate elongation of hemozoin
crystals, while conditional PV5 inactivation in the human malaria
agent Plasmodium falciparum causes excessive multidirectional
crystal branching. Although hemoglobin processing remains unaf-
fected, PV5-deficient parasites generate less hemozoin. Electron
diffraction analysis indicates that despite the distinct changes in
crystal morphology, neither the crystalline order nor unit cell of
hemozoin are affected by impaired PV5 function. Deregulation of
PV5 expression renders P. berghei hypersensitive to the antima-
larial drugs artesunate, chloroquine, and atovaquone, resulting in
accelerated parasite clearance following drug treatment in vivo.
Together, our findings demonstrate the Plasmodium-tailored role
of a lipocalin family member in hemozoin formation and under-
score the heme biomineralization pathway as an attractive target
for therapeutic exploitation.
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The devastating pathology of malaria is caused by infection ofred blood cells with unicellular Plasmodium parasites, which
reside within an intraerythrocytic parasitophorous vacuole (PV)
(1). Throughout blood-stage development, the parasite ingests
and catabolizes up to 80% of the host cell cytoplasm, facilitating
amino acid acquisition and making sufficient room for parasite
growth (2, 3). Hemoglobin is incorporated through endocytosis
and then degraded by an array of functionally redundant pro-
teases, a process that occurs in acidified lysosome-like organelles
with species-specific morphology (4). In the rodent-infective
parasite species Plasmodium berghei, one or more food vacu-
oles (FVs) give rise to small digestive vesicles (DVs), which only
fuse at the very end of intraerythrocytic development (5). In
contrast, the most virulent agent of human malaria, Plasmodium
falciparum, directs all endosomal traffic to a single large FV,
where proteolysis occurs (6).
Hemoglobin digestion is accompanied by the release of high
levels of the porphyrin cofactor heme from the globin chains.
Heme can damage proteins and lipids through various mecha-
nisms, including the formation of free radicals (7). The unique
challenge of heme detoxification is met by the parasite’s capacity
to sequester the released heme into a bioinert crystalline product
called hemozoin (Hz), which accumulates in the FV or DVs.
Heme is initially oxidized to yield hematin, which then dimerizes
through the reciprocal coordination of iron and propionate
moieties. This molecular unit then assembles into Hz crystals
that typically take the form of triclinic high aspect ratio paral-
lelograms (8–10). By the end of intraerythrocytic development,
all of the Hz crystals are contained within a central residual body,
which is eventually released upon parasite egress from the host
cell and which contributes to the inflammatory responses asso-
ciated with acute malaria (11). The mechanism of Hz formation
is highly debated. While several studies suggest a physicochem-
ical and autocatalytic crystallization process (12–15), there have
been reports of parasite proteins (16–18) and lipids (19–21)
promoting Hz assembly in vitro.
The parasite’s dependency on heme detoxification has long
been exploited in antimalarial therapy with outstanding success.
Aminoquinolines inhibit Hz formation via direct physical inter-
actions with hematin and the crystal surface, eventually leading
to the build-up of cytotoxic free heme (22–25). The amino-
quinoline chloroquine was the front-line medication against
malaria from the 1950s onward until the emergence of wide-
spread drug resistance restricted its utility (26). Nonetheless, to
this day chloroquine remains among the most effective antimalarial
drugs ever developed, highlighting the outstanding importance of
heme sequestration for Plasmodium survival. It is thus crucial for
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future drug development efforts to gain a better understanding
of the mechanisms underlying this unique biomineralization event.
In this report, we demonstrate that a parasite-encoded lipocalin
called PV5 is crucial for physiological heme biomineralization in
Plasmodium.
Results
Malaria Parasites Encode a Lipocalin-Like Protein, PV5. Employing a
genome-wide in silico down-scaling approach, we previously
identified an essential P. berghei PV protein, PbPV5 (PBANKA_
0826700), which has orthologs in all other Plasmodium species,
including P. falciparum (Pf) (PF3D7_0925900) (27). Inspection
of the PV5 amino acid sequence revealed a striking similarity to
members of the functionally diverse lipocalin family, barrel-
shaped proteins capable of binding various hydrophobic ligands
and protein interaction partners (28). The signature lipocalin
fold comprises a short amino-terminal 310 helix followed by eight
consecutive barrel-forming β-strands, an α-helix, and one more
β-strand (Fig. 1A) (29). In addition, PV5 harbors two predicted
preceding amino-terminal β-strands specific to Plasmodium, as
well as a signal peptide. Multiple sequence alignments with lip-
ocalins from phylogenetically distant organisms showed the
presence of a highly conserved glycine and two aromatic residues
within the structurally conserved region 1 (SCR1) of PV5, a
hallmark of the extended calycin superfamily (Fig. 1A) (29).
Among several structural homologs, the bacterial outer mem-
brane lipocalin Blc from Escherichia coli was predicted to share
the highest similarity with PV5. Homology modeling guided by
the known E. coli Blc structure suggests that PV5 shares the
overall architecture of the lipocalin family, including the char-
acteristic β-barrel (Fig. 1B). Together, the sequence signatures
and predicted structural features support membership of Plas-
modium PV5 in the calycin protein superfamily.
PV5 Is Trafficked to the Parasite Digestive Compartments. We first
investigated the spatiotemporal expression of PbPV5 during
asexual blood-stage development. Live fluorescence microscopy
of transgenic P. berghei parasites expressing mCherry-3xMyc-
tagged PbPV5 confirmed that the protein localizes to tubular PV
extensions during ring and trophozoite stages and surrounds
individual daughter merozoites in segmented schizonts (Fig. 1C)
(27). In addition, a substantial fraction of the protein was re-
stricted to the parasite cytoplasm. This was particularly prom-
inent in schizonts, where intraparasitic PbPV5 appeared to
localize to the Hz-containing residual body (Fig. 1C). In mero-
zoites, mCherry fluorescence was concentrated in a punctate
intraparasitic region, perhaps signifying storage of PbPV5 in the
dense granules, as has been demonstrated for several other im-
portant PV proteins (30–32), but this fraction was minimal as
compared to the protein contained in the residual body. Quan-
tification of the mCherry-fluorescence intensity in live parasites
indicated that PbPV5 is much more abundant in mature parasite
stages than in rings and merozoites, suggesting substantial levels
of de novo synthesis throughout parasite maturation (Fig. 1C). In
trophozoites, the intraparasitic fraction of PbPV5 was associated
with spherical structures at the parasite periphery (Fig. 1C) and
microscopic examination of mechanically expanded free para-
sites revealed that these were the Hz-containing DVs (Fig. 1D).
To test whether this localization is conserved across different
Plasmodium species, we generated and imaged transgenic P.
falciparum parasites expressing mCherry-tagged PfPV5 (Fig. 1E
and SI Appendix, Fig. S1). In younger parasite stages, fluores-
cence was restricted to one or more foci in the parasite periph-
ery. With parasite maturation, most of the fluorescent signal
overlapped with the Hz crystals and with the signal of the acid-
otropic dye Lysosensor blue DND-167, which accumulates in the
acidic FV (Fig. 1E and SI Appendix, Fig. S1D). This is in good
agreement with the reported detection of PfPV5 in the proteome
of purified P. falciparum FVs (33). In addition, we frequently ob-
served staining of the PV and of small foci in the parasite cytoplasm
(Fig. 1E and SI Appendix, Fig. S1D). Some trophozoites also
showed staining of a perinuclear region corresponding to the en-
doplasmic reticulum (SI Appendix, Fig. S1D). As in P. berghei, faint
fluorescent foci were observed associated with the budding merozo-
ites in mature P. falciparum schizonts (SI Appendix, Fig. S1D).
Western blot analysis indicated the presence of full-length
PfPV5-mCherry in the transgenic P. falciparum parasites (SI
Appendix, Fig. S1C). However, the predominant fraction of
mCherry appeared to have been cleaved off PfPV5, presumably
by the FV-resident proteases. This cleavage was not observed in
the tagged P. berghei line, possibly due to differences in the
spacer regions linking PbPV5 to the fluorescent protein. Sub-
cellular fractionation and Western blot analysis revealed that
full-length PbPV5-mCherry is freely soluble (Fig. 1F). Together,
our findings suggest that in both Plasmodium species, PV5 is
trafficked to the PV via the secretory pathway and then internalized
through endocytosis of host cell cytoplasm to eventually accumulate
in the matrix of the parasite’s digestive compartments.
Transcriptional Deregulation of PbPV5 Impairs Asexual Parasite
Propagation In Vivo. Our previous attempts to disrupt the geno-
mic PbPV5 locus resulted only in atypical integration of the
targeting construct without perturbing the endogenous gene,
which is indicative of essential functions during the asexual
blood-stage cycle in vivo (27). As an alternative genetic strategy
to analyze PbPV5 function, we sought to deregulate PbPV5 ex-
pression by employing a promoter swap approach (Fig. 2A).
Toward this aim, we generated parasites expressing the endog-
enous PbPV5 gene from the promoters of Plasmodium trans-
locon of exported proteins 88 (PTEX88) or heat shock protein 101
(HSP101), respectively (SI Appendix, Fig. S2 A and B). Quantitative
real-time PCR analysis of the mutants indicated that the knock-
down efficiency was ∼60% in asynchronous blood stages (SI Ap-
pendix, Fig. S2C). Impaired growth prevented quantification of
knockdown levels in synchronized ex vivo early blood stages.
Strikingly, in the schizont stage, the mutants exhibited significantly
elevated PbPV5 transcript levels, corresponding to ∼3.4 (pv5::5′
ptex88) and ∼5.6-fold (pv5::5′hsp101) more than in WT schizonts
(SI Appendix, Fig. S2C), showing that the promoter swap strategy
was successful in deregulating the physiological expression of PbPV5
throughout the asexual replication cycle.
To investigate whether altered PbPV5 transcription results in
reduced parasite fitness, we examined asexual propagation of the
mutants in vivo. Growth of the promoter swap mutants was
significantly impaired, with the pv5::5′ptex88 parasites growing at
80% and pv5::5′hsp101 parasites at only 54% of the WT growth
rate (Fig. 2B). These results underscore the importance of correct
PbPV5 expression during asexual replication of the parasite in vivo.
PbPV5 Mutants Form Less Hz. Inspection of Giemsa-stained thin
blood films revealed striking morphological differences between
WT parasites and the promoter swap mutants. In trophozoite
stages, the FV of the mutants was significantly swollen, visible as
a large bright area within the parasite cytoplasm close to the
nucleus (Fig. 2C). Microscopic quantification revealed this area
to be 1.5-fold (pv5::5′ptex88) or 1.8-fold (pv5::5′hsp101) larger
than in WT parasites (SI Appendix, Fig. S3A). Comparison of the
light intensities in the swollen FVs and the host cell cytoplasm
provided no indication for an accumulation of native hemoglobin
within the PbPV5 mutants (SI Appendix, Fig. S3 B and C). The
vacuolar swelling was transient, as mature schizonts did not ex-
hibit comparable abnormalities (Fig. 2C).
Another striking phenomenon was the low visibility of dark
granular material in mutant trophozoites, as compared to WT
(Fig. 2C). This lack of granularity was most noticeable in the
pv5::5′hsp101 mutant and became particularly apparent during
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the gametocyte stages, where pigment granules are usually very
prominent. To validate this finding, we subjected mixed blood-
stage parasites to flow cytometry and measured the intensity of
the side scattered light, a commonly used proxy for cellular
granularity (SI Appendix, Fig. S3D). In agreement with our mi-
croscopic analysis, the PbPV5 mutants displayed reduced side
scattering and the phenotype was again more severe in the
pv5::5′hsp101 mutant.
Because we suspected a Hz formation defect in the mutants,
we fixed intraerythrocytic parasites with methanol and subjected
them to polarization microscopy, which exploits the birefringent
properties of Hz to specifically visualize the crystals. This ap-
proach revealed a weaker signal for the mutants, which corre-
lated with reduced visibility of dark pigment in brightfield
(Fig. 2D). Enumeration of individual bright entities showed the
presence of fewer Hz-containing structures within the mutants
(∼80% of WT) (Fig. 2D). Quantification of the polarized light
intensity also indicated that pv5::5′ptex88 parasites form only
64% and the pv5::5′hsp101 61% of the Hz generated in WT
parasites (Fig. 2E). Together, these observations show that per-
turbation of PbPV5 expression results in reduced heme
biomineralization in vivo.
Protracted Hz Extension upon Deregulation of PbPV5 Expression. We
next aimed to examine how lower levels of Hz correlate with
crystal size. To do this, we isolated Hz from mixed blood-stage
parasites and examined the material by scanning electron mi-
croscopy (SEM). This confirmed the characteristic high aspect
G
FP
PV
M
er
ge
P
bP
V5
D
IC
 +
 D
N
A
Ring stage Trophozoite Schizont Merozoite
PbPV5 MergeDIC + DNA
N F D A K R Y GL FT W Y E I A REcBlc
N F D K A R F S G T W Y A M A K KHsRBP4
T P N R N S Y A G V W Y Q F TA LHgCCy
T L EEE ID T TG W Y V A MK VHsOBP2A
A TN L D Q I T G K W F Y I A ASHsAGP
D I D L K Q QL TG Y Y NAE I TPbPV5
PV5 only
SCR1
SP
TG F Y NAE I TN QLD V KN IPfPV5
0 
m
in
10
 m
in
EcBlc PfPV5 Overlay
PbEXP2-mCherry 70 kDa
27 kDa
58 kDaPbPV5-mCherry
GFPPV
TX-100
SN P
8.3% 67.1% 100% 17.4%
MergePfPV5 LS Blue DIC SN P
Na2CO3
Input SN
Lysate
C
D
A
E
B
F
Fig. 1. The Plasmodium lipocalin PV5 is trafficked to the parasite digestive compartments. (A) PV5 is a lipocalin family member. Secondary structure of
Plasmodium PV5. Yellow, signal peptide (SP); green, β-strands; purple, helices. Note the two amino-terminal β-strands specific to PV5. Alignments of the SCR1
from different lipocalin family members and PV5 are shown in the upper left corner. Signature residues are highlighted in red. EcBlc, Escherichia coli bacterial
lipocalin; HgCCy; Homarus gammarus (European lobster) crustacyanin; HsAGP, Homo sapiens α1-acid glycoprotein; HsOBP2A, H. sapiens odorant-binding
protein 2A; HsRBP4, H. sapiens retinol-binding protein 4; Pb/PfPV5, PV5 from P. berghei and P. falciparum. (B) Structure homology modeling predicts a
lipocalin fold for PfPV5. Shown are the experimentally validated structure of EcBlc (blue, Left, residues 27 to 175, PDB ID code 3MBT), the derived model of
PfPV5 (red, Center, residues 35 to 214) using EcBlc as a homology template, and an overlay (Right). Modeling was performed with SWISS-MODEL and
supported by I-TASSER. Amino acid sequence identity is 20%, similarity calculated from BLOSUM62 substitution matrix is 0.3. (C) Dual protein localization of
PV5 to extensions of the PV and to intraparasitic structures in P. berghei. Transgenic parasites expressing the PV marker GFPPV and the endogenous PbPV5
gene fused to mCherry-3xMyc were imaged live (27). Shown are the mCherry (red, first row) and GFP channels (green, second row), a merge of both signals
(third row) and a merge of differential interference contrast images (DIC), and Hoechst 33342 nuclear stain (blue, fourth row). Cyan arrowheads, PbPV5 in PV
tubules. Numbers represent normalized mCherry intensity values obtained by quantitative live fluorescence microscopy. n = 44 parasites. (D) Intraparasitic
PV5 localizes to Hz-containing DVs in P. berghei. Parasites (1 to 2 μL) were incubated under a coverslip (22 × 40 mm) for several minutes, leading to lysis of the
host erythrocyte and the PV, and to mechanical expansion of the parasite (Upper). Shown are a merge of DIC and Hoechst 33342 nuclear stain (blue, first
column), the signal of tagged PbPV5 (red, second column), as well as a merge of all three channels (third column). Swelling of PbPV5-containing DVs was
observed 10 min later (Lower). Note the even distribution of PbPV5 throughout the swollen DVs. (E) PV5 localizes to the central FV, intraparasitic vesicles and
to the PV in P. falciparum. Transgenic parasites expressing the endogenous PfPV5 gene fused to mCherry were imaged live in the presence of Lysosensor blue
DND-167 (LS Blue). Shown are the signals of mCherry (red, first column), LS Blue (green, second column), a merge of both signals (third column), and DIC
images (fourth column). Cyan arrowhead, PfPV5 in PV (Upper). Yellow arrowhead, PfPV5 in small intraparasitic vesicles (Lower). (Scale bars, 5 μm.) (F) PV5 is a
soluble protein. Subcellular fractionation was performed using the PbPV5-tagged P. berghei line, which also expresses the soluble marker GFPPV, and a P.
berghei line expressing the transmembrane protein PbEXP2 fused to mCherry-3xMyc (62). Cell lysates were centrifuged and resulting membrane pellets were
subjected to solubilization with Na2CO3 and Triton X-100 (TX-100). Input, supernatant (SN), and pellet fractions (P) were analyzed by Western blot using anti-
mCherry and anti-GFP primary antibodies.
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Fig. 2. Deregulated expression of PV5 impacts Hz formation in P. berghei. (A) Schematic representation of the genotypes of WT (Top), and transgenic pv5::5′
ptex88 (Middle) and pv5::5′hsp101 parasites (Bottom). In the mutants, the endogenous PbPV5 promoter (black) was exchanged for the promoter of PbPTEX88
(dark blue) or PbHSP101 (light blue), respectively. (B) Reduced parasite proliferation upon PbPV5 promoter swapping. Asexual blood-stage development was
analyzed using the intravital competition assay (53). Average parasite multiplication rates were 11.4 (WT), 9.1 (pv5::5′ptex88), and 6.2 (pv5::5′hsp101). Shown
are mean values ± SD. ***P < 0.001; two-way ANOVA. n = 3 independent infections. (C) Morphology of trophozoite, schizont, and gametocyte stages in the
WT, pv5::5′ptex88 and pv5::5′hsp101 lines as observed by Giemsa staining. Note the lack of prominent dark pigment granules in mutant trophozoites and
gametocytes as well as the dilation of the FV in mutant trophozoites. (Scale bar, 5 μm.) (D and E) PbPV5 is required for efficient Hz formation. (D) Tro-
phozoites were visualized by polarization microscopy (Left) and bright field imaging (Right). Numbers indicate the mean quantity of bright puncta in po-
larization images. Significance values are shown for the comparison of the mutants with WT. (Scale bar, 5 μm.) (E) Quantitative polarization microscopy.
Depicted are individual and mean intensity values of reflected polarized light in methanol-fixed WT, pv5::5′ptex88 and pv5::5′hsp101 trophozoites (bars,
upper graph). Only trophozoites of similar size were analyzed (lower graph). Depicted are mean values ± SD. n.s., nonsignificant; *P < 0.05; ***P < 0.001; one-
way ANOVA and Tukey’s multiple comparison test. n = 80 trophozoites from four independent infections. (F) Hz crystal architecture. In WT Plasmodium
parasites Hz assembles as triclinic high aspect ratio parallelograms (64). Characteristic crystal axes and faces are indicated. (G) SEM images of Hz purified from
WT, pv5::5′ptex88 and pv5::5′hsp101mixed blood-stage parasites. The angle between the regularly shaped pv5::5′hsp101 parent crystal and the outgrowth is
indicated. n = 130 crystals. (Scale bars, 100 nm.) (H) Crystal morphology in situ. Shown are TEM images of WT, pv5::5′ptex88 and pv5::5′hsp101 schizonts
(Upper) as well as their residual body at higher magnification (Lower). Abnormal crystal shapes in the mutants are indicated by arrowheads. (Scale bars, 500
nm.) (I) Hyperactive Hz growth is unidirectional. Shown are the dimensions of whole individual Hz crystals extracted from WT, pv5::5′ptex88, and pv5::5′
hsp101 parasites, including the area exposed to the electron beam (Left) as well as the length (Center) and mean width of the crystals (Right). The theoretical
dimensions of the pv5::5′hsp101 parent crystals were interpolated and are depicted as well. Shown are mean values ± SD. n.s., nonsignificant; *P < 0.05;
***P < 0.001; one-way ANOVA and Tukey’s multiple comparison test. n = 100 crystals. (J) Normal aspect ratio of pv5::5′hsp101 parent crystals. Shown are the
aspect ratios of whole Hz crystals from WT parasites and of the parent crystal from pv5::5′hsp101-generated Hz. Depicted are individual and mean values
(bars). n.s., nonsignificant; Student’s t test. n = 100 crystals. (K and L) Unaltered crystalline order in Hz of pv5::5′hsp101 parasites. (K) Depicted are TEM images
(Left) of Hz purified from WT and pv5::5′hsp101 parasites as well as their corresponding electron diffraction patterns (Right) showing comparable resolution
of the Bragg peaks. Dashed circles demark a resolution of 0.5 Å−1. (Scale bars, 200 nm.) (L) Plot of the radial maximum diffracted intensity as a function of
resolution. Data were normalized to the average median intensity at 0.18 Å−1 in order to correct for differences in diffracted volume. Arrowheads denote
overlapping peaks. n = 10 (WT) and 18 (pv5::5′hsp101) diffraction datasets.
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ratio parallelogram morphology of WT Hz (Fig. 2 F and G).
Strikingly, this was not the case for crystals isolated from the
promoter swap mutants. Hz from both transgenic parasite strains
exhibited highly irregular shapes and rough edges and showed
only few of the distinctive Hz crystal vertices (Fig. 2G). Crystals
from pv5::5′ptex88 parasites most often had a pointed and canine
tooth-like appearance, extending from a single straight crystal
face. These abnormalities were even more pronounced in the
pv5::5′hsp101 mutant, where in most cases there was a region of
normal crystal morphology with two or three straight edges,
corresponding to the {010}, {011}, and {001} faces. From this
regular parent crystal emerged an enormous outgrowth that
usually surpassed the dimensions of the parent crystal (Fig. 2G).
This outgrowth consistently grew at an obtuse angle of ∼105° in
relation to the dominant c axis of the parent crystal, although
accurate determination of the angle was complicated by the
slightly bent and irregular shape of the outgrowth, which might
be attributed to the space restrictions encountered in the P.
berghei DVs. The outgrowth’s angle was not reflected in the
physiological morphology of Hz (Fig. 2 F and G) and at least two
faces of the regular parent crystal appeared to be involved. In-
deed, in most cases the outgrowth emerged from sites where the
{010} and {011} faces meet and always grew along a plane
corresponding to one of the original crystal faces (Fig. 2G).
Other crystal formations were also observed, albeit at lower
frequency, including some with multiple crystal branches and
some with very rough surfaces (SI Appendix, Fig. S3E). We ob-
served similar crystal abnormalities in situ by transmission elec-
tron microscopy (TEM) of purified schizonts (Fig. 2H).
Despite the lower overall levels of Hz formed and the ab-
normal crystal morphology, we found that the mutants formed
larger Hz crystals, as indicated by the area exposed to the SEM
electron beam (Fig. 2I). The pv5::5′hsp101 mutant formed the
largest crystals, which were ∼180% of WT size, while the pv5::5′
ptex88 crystals were at 130%. Importantly, the mutant Hz crystals
displayed greater dimensions only in length but not in width
because of the unidirectional expansion of the outgrowth
(Fig. 2I). Examination of the parent crystals from pv5::5′hsp101
parasites showed that these were roughly half the size of whole
WT crystals (Fig. 2I). The aspect ratios of WT crystals and the
pv5::5′hsp101 parent crystals were identical, together indicating
that a period of normal crystallization during early pv5::5′hsp101
parasite development is followed by irregular crystal extension
later on (Fig. 2J). Hz morphology was unaffected in an unrelated
slow-growing mutant (34) and in chloroquine-treated WT para-
sites, suggesting that Hz crystal dysmorphism, as observed in the
PbPV5 mutants, is not a phenomenon generally associated with
poor parasite growth or mortality (SI Appendix, Fig. S3 F and G).
To determine whether the crystalline order was affected by
deregulation of PbPV5, we obtained electron diffraction patterns
from WT- and pv5::5′hsp101-derived Hz (Fig. 2K) and analyzed
the maximum diffracted intensities in concentric bins as a func-
tion of resolution. There was no difference in the drop-off of
diffracted intensity between WT and mutant and the peak po-
sitions of the maxima corresponded (Fig. 2L). Differences in the
magnitude of individual peaks can be attributed to preferential
orientation, especially of the pv5::5′hsp101-derived crystals,
which most often come to lie at their {100} faces. Together,
these data indicate no differences in crystalline order or unit cell
upon functional impairment of PbPV5.We conclude that altered
crystal morphology is not caused by alternative nucleation into a
different hematin polymorph. Thus, deregulation of PbPV5 leads
to the formation of ordered elongated Hz crystals with a highly
variable and abnormal architecture.
Loss of PV5 Causes Hz Branching in P. falciparum. To investigate the
consequences of PV5 disruption, we generated a conditional PV5
knockout line of the human pathogen P. falciparum, allowing
rapamycin (RAP)-induced DiCre-mediated excision of the
PfPV5 gene (Fig. 3A and SI Appendix, Figs. S1A and S4A).
Correct modification of the locus was indicated by diagnostic
PCR and by the successful tagging of PfPV5 with a 3xHA tag, as
demonstrated by Western blot and immunofluorescence analysis
(Fig. 3 B and C and SI Appendix, Fig. S3 B–E). The 3xHA-tagged
PfPV5 localized to the PV and to intraparasitic vesicular struc-
tures (SI Appendix, Fig. S4B). Surprisingly, no signal was de-
tected in the FV. However, global inhibition of the parasite’s
cysteine proteases with E64 restored localization of 3xHA-
tagged PfPV5 to the FV and significantly increased the amount
of tagged protein, together suggesting that the 3xHA tag is
proteolytically cleaved upon FV delivery (SI Appendix, Fig. S4 C
and D).
Treatment of pv5-3xHA:loxP parasites with RAP led to effi-
cient gene excision and complete loss of PfPV5 protein expres-
sion during the same intraerythrocytic cycle (Fig. 3 B and C and
SI Appendix, Fig. S4E). This did not detectably affect parasite
maturation but did result in a modest merozoite invasion defect
upon rupture of the PfPV5-null schizonts, reducing parasite
replication (SI Appendix, Fig. S5). Extended monitoring of the
RAP-treated parasites indicated an estimated fitness cost of
∼40% (SI Appendix, Fig. S5B). This is in good agreement with a
proposed mutagenesis index score of 0.22 from a genome-wide
piggyBac insertion screen (35). Accordingly, PfPV5, although not
essential under standard P. falciparum culture conditions, is re-
quired for optimal parasite propagation in vitro.
To examine the effects of PfPV5 ablation on heme bio-
mineralization, Hz was visualized and quantified by polarization
microscopy. RAP-treated pv5-3xHA:loxP parasites formed only
57% of the Hz observed in WT and DMSO-treated controls and
individual crystals appeared to be globular rather than elongated
(Fig. 3 D and E). In the absence of PfPV5, Hz released at par-
asite egress no longer formed clusters of separate slender crystals
but rather appeared as aggregates that only occasionally fell
apart into individual units (Fig. 3F). In good agreement, micro-
scopic inspection of live parasites revealed that the characteristic
twirling motion of Hz within the central FV was lost upon PfPV5
knockout (Fig. 3G and Movie S1).
The dramatic abnormalities in Hz crystal morphology resulting
from ablation of PfPV5 were even more evident by SEM analysis.
While WT parasites formed crystals of the expected brick-like
morphology, individual Hz units from RAP-treated pv5-3xHA:
loxP parasites appeared smaller and more globular (Fig. 3H and
SI Appendix, Table S1). The surfaces of these Hz units were
covered in scales and stubby crystal buds. Individual crystals of
comparable bud-like dimensions were not observed, indicating a
branching rather than an aggregation phenomenon. In some
instances, a lower number of crystal buds allowed the visualiza-
tion of an ordered Hz core, suggesting that branching is initiated
from a regular parent crystal (Fig. 3H). We detected several
morphological intermediates between slightly scaled Hz, highly
branched crystal units, and fused congregations (Fig. 3H). We
frequently observed enormous aggregates of spherical propor-
tions, mirroring the shape of the central FV (Fig. 3H). This
suggested that hyperactive crystal branching in the absence of
PfPV5 caused individual studded Hz units to stick together and
subsequently merge during Hz growth, which might explain the
absence of motion in the parasite FV (Fig. 3G). NonRAP-
treated pv5-3xHA:loxP control parasites mainly formed regular
Hz crystals; however, 27.5% of the crystals exhibited a modest
degree of branching (Fig. 3H and SI Appendix, Table S1). Fur-
thermore, crystal size and aspect ratio were reduced in com-
parison to WT parasites, suggesting a moderate functional
impairment of 3xHA-tagged PfPV5 (Fig. 3H and SI Appendix,
Table S1). Our data demonstrate that PV5 is critical for the
efficient sequestration of heme and for the ordered expansion of
Hz crystals in P. falciparum.
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Efficient Hemoglobin Processing in the Absence of PfPV5. To exclude
an indirect effect mediated by defective hemoglobin catabolism,
we examined the hemoglobin content of saponin-released para-
sites. PfPV5-deficient ring stages and trophozoites contained
normal quantities of internalized hemoglobin (Fig. 4A). Only
mature segmented pv5-3xHA:loxP schizonts exhibited slightly
elevated concentrations of residual hemoglobin upon induction
(Fig. 4B). However, this was also observed in WT schizonts upon
RAP treatment, suggesting a minor compound-specific effect.
In WT parasites, inhibition of the vacuolar cysteine proteases
with E64 caused significant bloating of the FV, because of an
accumulation of undigested hemoglobin (Fig. 4C). A comparable
bloating phenotype was not observed in untreated PfPV5-null
parasites, which retained normal FV morphology. We also
noted that, unlike PfPV5 deletion, E64 treatment produced no
changes in the architecture of Hz (Fig. 4D), and PfPV5-deficient
parasites retained normal E64 sensitivity (Fig. 4 E and F). Fur-
thermore, saponin treatment released normal amounts of he-
moglobin from schizont-infected erythrocytes in the absence of
PfPV5, indicating unaltered hemoglobin ingestion (Fig. 4B).
Combined, these findings suggest that inhibition of hemoglobin
catabolism does not directly translate into altered Hz morphol-
ogy and that PfPV5 is not involved in the overall consumption of
host cell cytoplasm.
PbPV5 Expression Influences Antimalarial Drug Sensitivity In Vivo. In
the light of our evidence implicating PV5 in Hz formation, we
next tested whether parasites with affected PV5 function display
altered sensitivity toward chloroquine, a 4-aminoquinoline which
is thought to inhibit heme biomineralization in Plasmodium
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microscopy 36 h after invasion. (D) Quantification of the polarized light intensity. Depicted are values from individual parasites as well as the mean intensity
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Exemplary images of DMSO- and RAP-treated pv5-3xHA:loxP parasites. Shown is a merge of polarized light (cyan) and DIC. (Scale bar, 5 μm.) (F) Abnormal Hz
morphology in the absence of PfPV5. Hz released from residual bodies during parasite egress was imaged in Giemsa-stained thin culture smears of DMSO- and
RAP-treated pv5-3xHA:loxP parasites. Note the spreading of elongated Hz crystals in DMSO-treated cultures and the clumping of granular Hz upon RAP
treatment (Left). Only in very few instances did the crystals detach from one another in RAP-treated cultures (Right). (Scale bar, 5 μm.) (G) Reduced Hz
movement in the FV upon loss of PfPV5. Shown are DIC images of live DMSO- and RAP-treated pv5-3xHA:loxP parasites 36 h after invasion. Parasites were
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(22–25). The absence of PfPV5 did not detectably alter sensi-
tivity toward chloroquine or any other tested antimalarial drug in
cultured P. falciparum parasites (SI Appendix, Fig. S6). In stark
contrast to this, however, the P. berghei promoter swap mutants
responded to chloroquine treatment slightly earlier and dis-
appeared from the circulation much more rapidly than WT
parasites (Fig. 5A). A similar phenotype was observed upon
treatment of infected mice with the artemisinin derivative arte-
sunate, which has also previously been implicated in heme se-
questration, although this remains contentious (36–40) (Fig. 5B).
Most surprisingly, we also observed marked hypersensitivity of
the P. berghei mutants toward atovaquone, a compound that
targets the parasite’s mitochondrial electron transport chain
(Fig. 5C), as well as a slight but nonsignificant increase in sen-
sitivity toward the antifolate sulfadoxine (Fig. 5D). The relative
survival levels of pv5::5′ptex88 and pv5::5′hsp101 on the
fourth day of drug treatment suggested the greatest degree of
hypersensitivity toward chloroquine (2.1% and 1.4% of WT
survival, respectively), followed by atovaquone (3.5% and 8.6%)
and artesunate (4.4% and 9.9%), and eventually sulfadoxine
(20.5% and 27.8%). An unrelated slow-growing P. berghei mu-
tant deficient in the maintenance of the mitochondrial mem-
brane potential displayed normal sensitivity toward atovaquone
using the same internally controlled assay (41), indicating that
reduced parasite multiplication is unlikely to cause drug hyper-
sensitivity. Collectively, these results suggest that interference
with PV5 expression critically enhances vulnerability of the par-
asite toward drug-mediated insult during in vivo blood infection.
Discussion
In this work, we have demonstrated that Hz formation in malaria
parasites involves a secreted calycin family member called PV5.
While transcriptional deregulation of PV5 in P. berghei resulted
in protracted Hz elongation along a preexisting crystal plane,
multidirectional branching was observed in the complete absence
of PV5 in P. falciparum. Species differences aside, the disparity
between those two phenotypes can be explained by the unique
transcriptional dynamics observed in the P. berghei mutants.
Here, the hyperactive crystal elongation that follows an initial
phase of normal Hz growth coincides with a substantial increase
in PbPV5 transcript abundance during late parasite develop-
ment. In their physiological context, PTEX88 and HSP101 are
coexpressed as members of the same protein complex, with
HSP101 being more abundant than PTEX88 (42, 43), as sup-
ported by our qPCR analysis. Thus, the increased phenotypic
severity in the pv5::5′hsp101 mutant over the pv5::5′ptex88 mu-
tant indicates that the deficiencies in Hz formation can be at-
tributed to late overexpression of PV5. Together with the chaotic
Hz crystal branching observed in PV5-deficient P. falciparum
parasites, this leads us to propose that PV5 acts as a facilitator of
unidirectional Hz extension.
The highly polymorphic appearance of Hz in the absence of
PV5 is reminiscent of the variable crystal morphology following
β-hematin formation in vitro (12). While the exact biophysical
mechanisms that govern PV5-mediated Hz morphogenesis re-
main to be delineated, our results support a model of conven-
tional crystallization within the aqueous milieu of the parasite’s
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digestive compartments. The distinct changes in crystal mor-
phology and branching behavior in the PV5 mutants concur with
established mineralogical phenomena and are difficult to rec-
oncile with a lipid or protein-mediated polymerization scenario.
It is interesting to speculate on the mechanisms by which PV5
may partake in heme biomineralization. In laboratory crystalli-
zation experiments, the extent of crystallographic mismatch
branching is highly dependent on the degree of solute super-
saturation, with high levels favoring the generation of novel
crystal nuclei on the surface of the parent crystal (44). In con-
trast, lower degrees of supersaturation usually promote the ex-
pansion of preexisting crystals (44). It is conceivable that PV5
might reduce the extent of heme supersaturation by binding
heme or hematin dimers, thereby moderating de novo Hz nu-
cleation and promoting unidirectional crystal elongation. This
could explain the Hz branching upon loss of PV5 in P. falcipa-
rum, as well as the prolonged crystal elongation and reduced Hz
production upon late up-regulation of PV5 in the P. berghei
mutants. In support of this model, some lipocalin family mem-
bers are known to specifically bind the heme degradation prod-
uct biliverdin (45–47). Such interactions are unlikely to occur
within the predicted PV5 β-barrel due to spatial constraints.
However, although experimental validation for this is currently
lacking, potential ligand binding sites might be located at the
predicted prominently exposed loop between the barrel’s
β-strands 5 and 6 (Fig. 1B) or at the extended amino terminus.
The molecular functions of PV5 might also involve protein–
protein interactions, as lipocalins from various organisms share
the tendency to oligomerize and form complexes with different
proteins and membrane receptors (28, 29).
The crystal branching characterizing PV5-deficient P. falcipa-
rum parasites could also be elicited by nonheme impurities
adsorbing onto the crystal surface, where they would generate
novel nucleation sites (44). In this alternative functional model,
PV5 could act to bind these impurities to create a vacuolar en-
vironment permissive for proper biomineralization. PfPV5-
deficient parasites maintain an intact FV with a transvacuolar
proton gradient as indicated by staining with Lysosensor blue
DND-167 (SI Appendix, Fig. S7A). In the absence of indications
for FV membrane damage, differences in leakage of impurities
from the parasite cytoplasm appear unlikely. However, we can-
not rule out the possibility that specific ions or organic com-
pounds are more abundant in the vacuolar matrix of PV5-
deficient parasites.
The striking localization pattern of PV5 is suggestive of initial
secretion into the PV followed by endocytic uptake. Since we
ruled out an involvement of PV5 in hemoglobin ingestion and
catabolism, the transient vacuolar swelling in the P. berghei
mutants likely reflects a secondary effect mediated by the grave
deficiencies in heme sequestration. This is supported by a pre-
vious report demonstrating that defective hemoglobin catabolism
causes chloroquine resistance in P. berghei (48), a phenotype that
is in stark contrast to our own observations.
Our previous experiments had indicated that PbPV5 is essen-
tial for asexual blood-stage development in P. berghei (27), and
the deregulation of PbPV5 transcription in the mutants described
here indeed led to a striking fitness cost during in vivo infection.
In contrast, complete ablation of PfPV5 in P. falciparum only
resulted in a moderate fitness loss in vitro. The apparent dis-
pensability of PfPV5 is therefore puzzling, but can be resolved by
the notion that in vitro culture does not necessarily reflect all
adversities encountered during host infection. For example, Hz-
mediated stiffening of the residual body in the absence of PV5
might hinder the passage of infected cells through capillaries or
through the interendothelial slits of the spleen, a scenario that
would result in parasite elimination only during in vivo infection.
Similarly, we observed enhanced drug susceptibility only in the P.
berghei mutants. Thus, it appears plausible that any imbalance in
heme biomineralization in the absence of PV5 is compensated
for under optimal culture conditions, revealing its adverse effects
only during in vivo infection. We thus propose that the molecular
mechanism by which PV5 regulates Hz formation might involve
host factors that are not encountered in a cell culture setting.
The observation of enhanced drug susceptibility in the PbPV5
mutants is in agreement with the notion that aberrant heme
biomineralization chemo-sensitizes parasites to partner drugs.
Although oxidative stress and lipid peroxidation remained un-
changed upon deletion of PfPV5 (SI Appendix, Fig. S7B), the
reduced Hz formation efficiency in the PV5 mutants suggests
elevated heme concentrations within the parasite mediating the
fitness loss and drug hypersensitivity.
In summary, we provide conclusive evidence for a parasite
factor mediating Hz formation in vivo. Since this Plasmodium-
encoded member of the calycin superfamily also governs parasite
viability and susceptibility to drug-mediated insult during blood
infection, our observations reinforce Hz formation as an excel-
lent pathway for therapeutic intervention. Further investigation
of the parasite heme detoxification machinery in vivo, as exem-
plified here for PV5, will significantly improve our understanding
of this unique biomineralization process and holds great promise
for the development of novel malaria intervention strategies.
Materials & Methods
Structure Homology Modeling. Structure homology modeling was performed
using the SWISS-MODEL server (49). PfPV5 (residues 35 to 214) was aligned
to the experimentally validated structure of EcBlc (residues 27 to 175, PDB ID
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Fig. 5. Targeting PV5 function results in parasite hypersensitivity toward
antimalarial drugs in vivo. Enhanced drug susceptibility of the PbPV5 mu-
tants in vivo. The 5 × 106 mCherry-fluorescent P. berghei WT parasites were
injected into SWISS mice together with 5 × 106 GFP-fluorescent pv5::5′ptex88
or pv5::5′hsp101 parasites, respectively. From day 3 onward, mice were
treated with curative doses of (A) chloroquine (288 mg/L in drinking water,
ad libitum), (B) artesunate (50 mg/kg body weight, i.p.), (C) atovaquone
(1.44 mg/kg body weight, i.p.) or (D) sulfadoxine (1.4 g/L in drinking water,
ad libitum). Subsequent parasitaemia values were determined daily by flow
cytometry of peripheral blood (41). Values are normalized in each case to
the parasitaemia on day 0 of treatment. Shown are mean values ± SEM. n.s.,
nonsignificant; *P < 0.05; **P < 0.01; Two-way ANOVA. n = 3 independent
experiments.
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code 3MBT) (50), resulting in a global model quality estimate value of 0.39
and a qualitative model energy analysis value of −5.48. Modeling was con-
firmed with I-TASSER (51), which also identified EcBlc (PDB ID code 2ACO)
(52) as the most closely related structural analog of PfPV5 with a template
modeling score of 0.75. Due to a lack of sequence similarity, the structure of
the extended PfPV5 amino terminus was not modeled.
P. berghei Cultivation. P. berghei parasites were propagated in SWISS mice
under constant drug pressure with pyrimethamine (70 mg/L in drinking
water, ingested ad libitum; MP Biomedicals) to avoid homology-induced
reversion of the promoter swap mutants to the original WT genotype.
This was routinely checked by diagnostic PCR of genomic DNA as shown in SI
Appendix, Fig. S2 A and B. Drug pressure was withdrawn 5 d prior to ex-
perimentation to avoid secondary effects of pyrimethamine treatment.
Pyrimethamine-resistant Berred WT parasites (53) were treated accordingly.
All infection experiments were carried out in strict accordance with the
German “Tierschutzgesetz in der Fassung vom 22. Juli 2009” and the Di-
rective 2010/63/EU of the European Parliament and Council “On the pro-
tection of animals used for scientific purposes.” The protocol was approved
by the ethics committee of the Berlin state authority (“Landesamt fur Ge-
sundheit und Soziales Berlin,” permit no. G0294/15).
P. berghei growth was determined with the previously described in-
travital competition assay (53). In short, 500 mCherry-fluorescent Berred WT
and 500 GFP-fluorescent mutant blood-stage parasites were coinjected in-
travenously and parasitaemia was analyzed daily by flow cytometry. For
drug sensitivity assays, 5 × 106 WT and 5 × 106 mutant parasites were
coinjected intravenously. Drug treatment as well as daily flow cytometric
parasite detection were commenced 3 d later (41). Mice were treated with
curative doses of chloroquine (288 mg/L in drinking water, ingested ad
libitum; Sigma Aldrich), atovaquone (1.44 mg/kg body weight per day in-
jected intraperitoneally; GlaxoSmithKline), artesunate (50 mg/kg body weight
per day injected intraperitoneally; Sigma Aldrich), or sulfadoxine (1.4 g/L in
drinking water, ingested ad libitum; Sigma Aldrich). Mixed blood stages and
schizonts were purified by Nycodenz gradient centrifugation (54).
P. falciparum Cultivation. P. falciparum parasites were propagated in type
AB+ human red blood cells at 90% N2, 5% CO2, and 5% O2 at 37 °C in RPMI
1640 containing AlbuMAXII (Thermo Fisher Scientific) supplemented with
2 mM L-glutamine. Parasites were routinely synchronized using a combina-
tion of Percoll gradient centrifugation and sorbitol lysis and were treated
with 100 nM RAP, various concentrations of E64 or equivalent volumes of
DMSO from the early ring stage onward. Growth assays were performed as
described previously (55) and parasitaemia as well as DNA content were
measured by flow cytometry using the nuclear dye SYBR Green (1:10,000;
Thermo Fisher Scientific). For invasion assays, mature schizonts were in-
cubated at 2% initial parasitaemia under static or shaking (120 rpm) con-
ditions, as confirmed by flow cytometry. Parasitaemia was measured again
24 h after inoculation and the fold-change was calculated. For drug- and
inhibitor-response analyses, pv5-3xHA:loxP ring-stage cultures at 0.5 to 2%
parasitaemia were treated with varying concentrations of chloroquine,
WR99210, artesunate, atovaquone, or E64 in the presence of DMSO or RAP
in a 96-well format. Parasitaemia was determined 3 d later and the fold-
change was calculated. E64 was washed out after 36 h to allow for reinva-
sion. In addition, nuclear SYBR Green fluorescence was determined by flow
cytometry following 44 h of continuous E64 treatment.
Generation and Validation of Transgenic Plasmodium Parasites. To generate
the PbPV5 promoter swap mutants, the 5′ portion of the PbPV5 gene
(PBANKA_0826700) was PCR-amplified and cloned into the B3D+ vector us-
ing BamHI and SacII. The promoters of PbPTEX88 (PBANKA_0941300) or
PbHSP101 (PBANKA_0931200) were then amplified and cloned in front of
the start codon using BamHI (SI Appendix, Fig. S2A). Vectors were linearized
with BstBI and transfected into GFP-fluorescent P. berghei Bergreen WT
parasites, using standard protocols (54, 56, 57). Transgenic parasites were
selected for with pyrimethamine and isolated by limiting dilution cloning.
PbPV5 transcript abundance in the WT and the promoter swap mutants was
measured by quantitative real-time PCR (qPCR) and normalized to Pb18S rRNA.
The conditional PfPV5 knockout lines were generated using established
Cas9-mediated techniques. In short, P. falciparum B11 parasites constitu-
tively expressing DiCre were cotransfected with a pDC2 guide plasmid in-
ducing Cas9-mediated double strand cleavage of the PfPV5 locus
(PF3D7_0925900), together with a linearized repair template (58–60) (SI
Appendix, Fig. S3A). The template was generated by gene synthesis and
contained 5′ and 3′ homology arms and a recodonised 3xHA-tagged PfPV5
sequence. The endogenous intron of PfPV5 was replaced with an artificial
intron containing a loxP site (59). A second loxP sequence was introduced
downstream of the PfPV5 stop codon. For live imaging of PfPV5, mCherry
was cloned into the conditional knockout vector in frame with the
recodonised PfPV5 sequence using AatII. Transgenic parasites were selected
with WR99210 and cloned by limiting dilution using of a previously de-
scribed plaque assay (61). Primers used for molecular cloning, diagnostic PCR,
and qPCR are indicated in Fig. 3A and in SI Appendix, Figs. S1A and S2A and
Table S2.
Fluorescence Microscopy. The transgenic P. berghei parasite line pv5-tag-GFPPV
(27) was imaged live using an AxioImager Z2 epifluorescence microscope
equipped with an AxioCam MR3 camera (Zeiss). For mechanical parasite ex-
pansion, 1 to 2 μL of infected blood was incubated under a 22 × 40-mm coverslip
for several minutes until erythrocyte lysis became apparent. P. falciparum par-
asites were imaged on an Eclipse Ni light microscope (Nikon) fitted with a
C11440 digital camera (Hamamatsu). Immunofluorescence analysis was per-
formed with P. falciparum pv5-3xHA:loxP parasites that were fixed in 4%
formaldehyde using rat anti-HA (1:500; Sigma Aldrich) and rabbit anti-SERA5
(1:500) (55) primary antibodies in combination with appropriate fluorophore-
coupled secondary antibodies (1:1,000; Thermo Fisher Scientific). Staining with
Lysosensor blue DND-167 (Thermo Fisher Scientific), BODIPY 581/591 C11
(Image-iT Lipid Peroxidation Kit, Thermo Fisher Scientific), and CellROX Green
(Thermo Fisher Scientific) was performed according to the manufacturer’s
instructions.
Scanning Electron Microscopy. Hz was isolated from Nycodenz (P. berghei) or
Percoll (P. falciparum) enriched infected red blood cells. Cells were lysed in
water at room temperature for 20 min, followed by a 10-min centrifugation
step at 17,000 × g. The pellet was resuspended in 2% SDS in water and
centrifuged as above. Three more washing steps with 2% SDS were then
followed by three washing steps with distilled water, before the crystals
were resuspended and transferred onto round glass coverslips (12 mm),
where they were dried. Coverslips were mounted on SEM specimen stubs,
sputter-coated, and then imaged on a LEO 1430 (Zeiss) or on a Quanta FEG
250 SEM (Thermo Fisher Scientific).
Transmission Electron Microscopy. Infected erythrocytes were fixed in 2.5%
glutaraldehyde, embedded in beads of 2% agarose, treated with 1% osmium
tetroxide, and further contrasted en bloc using 0.5% uranyl acetate. Fol-
lowing dehydration in a graded series of ethanol and propylene oxide,
beads were embedded in epoxy resin and cured at 60 °C for at least 24 h. The
60-nm sections were produced with a Reichert Ultracut S ultramicrotome
(Leica) using a diamond knife. Sections were retrieved on copper hexagonal
mesh grids, and stained with 2% uranyl acetate and Reynold’s lead citrate
before imaging on an EM 900 TEM (Zeiss) equipped with a wide-angle slow-
scan 2K CCD camera (Tröndle Restlichtverstärkersysteme).
Electron Diffraction. Purified Hz was added to glow-discharged Lacey carbon
films on 400-mesh copper grids, which were then transferred to a Vitrobot
Mark IV plunge freezer (Thermo Fisher Scientific) with 100% humidity at
7 °C. The grids were blotted for 3 s with blot force 1 and plunged frozen in
liquid ethane cooled by liquid nitrogen. Electron diffraction data were col-
lected on a Talos cryoelectron microscope (Thermo Fisher Scientific) oper-
ated at 200 keV equipped with a hybrid pixel Timepix detector (512 × 512
pixels, 55 × 55 μm pixel size; Amsterdam Scientific Instruments). Still and
rotation (70°) datasets were collected with a beam size of 2 μm. The re-
cording time varied between 15 and 100 s. To determine the resolution, a
powder pattern of an aluminum diffraction standard was recorded. Since
the Hz crystals had a strong tendency to stick together, we measured dif-
fraction data of crystal clusters. For each individual dataset, we determined
the location of the central electron beam and shifted the patterns to make
the beams coincide. Since crystal clustering prevented indexing of the dif-
fraction data, the radial median and maximum intensities were determined
as a function of resolution. Hereafter, the WT and pv5::5′hsp101 datasets
were averaged and normalized to the local background median intensity at
0.18 Å−1.
Subcellular Fractionation and Immunoblotting. P. falciparum parasites were
released from erythrocytes by treatment with 0.15% saponin in PBS. Murine
erythrocytes infected with the pv5-tag-GFPPV or exp2-mCherry P. berghei
lines (62) were purified on a Nycodenz gradient and lysed hypotonically for
1 h on ice in 10 mM Tris·HCl, pH 7.5. P. berghei lysates were centrifuged for
50 min at 100,000 × g. Membrane pellets were resuspended in 0.1 M Na2CO3
in PBS or in 1% Triton X-100 in PBS, respectively, and centrifuged for 50 min
at 100,000 × g. Proteins were separated on SDS-polyacrylamide and
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transferred to nitrocellulose membranes. Western blotting was performed
using rat anti-mCherry (1:5,000; ChromoTek), chicken anti-GFP (1:5,000;
Abcam), rat anti-HA (1:1,000; Sigma Aldrich), rat anti-PfBiP (1:1,000) (63),
and rabbit anti-human hemoglobin α-primary antibodies (1:1,000; Abcam)
followed by chemiluminescence detection with horseradish peroxidase-
coupled secondary antibodies (1:10,000; Sigma Aldrich, or 1:5,000; Jackson
ImmunoResearch).
Quantitative Hz Analysis. Hz was visualized and quantified microscopically in
methanol-fixed infected red blood cells. Hz from P. berghei was analyzed by
reflection contrast polarized light microscopy using a Leica DMR widefield
microscope equipped with a ProgRes MF camera (Jenoptik) and the POL
filter set 513813 (Leica). Hz from P. falciparum was analyzed by transmitted
polarized light (488 nm) microscopy using an LSM 710 confocal microscope
(Zeiss) equipped with a crossed polarizer in the condenser. Cellular granu-
larity was approximated by quantification of side scattered light using an
LSRFortessa flow cytometer (BD Biosciences). Hz crystal dimensions were
analyzed using FIJI. Due to the variation in the P. berghei mutant’s crystal
width, individual crystals were divided into nine evenly spaced segments
along the dominant axis. The width of each segment was determined and
the values were averaged. For the pv5::5′hsp101 parent crystal and the
crystal outgrowth, transects were drawn through the central axis of either
structure and their shared angle was determined. Hz movement within the
FV of pv5-3xHA:loxP parasites was imaged live 36 h following treatment
with DMSO or RAP.
Data Availability.All data are presented in themain text or are available in the
SI Appendix. Generated plasmids and parasite lines are available from the
corresponding author.
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